Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization

BACKGROUND: The immunogenicity of booster inactivated COVID‐19 vaccines in patients with type 2 diabetes mellitus (T2DM) has remained unclear. Our study aims to investigate the antibody response to inactivated COVID‐19 vaccine following booster vaccination in patients with T2DM. METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haolong, Wang, Yao, Li, Xiaomeng, Wang, Siyu, Feng, Xinxin, Xiao, Xinhua, Li, Yongzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Editor's Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667667/
https://www.ncbi.nlm.nih.gov/pubmed/37518861
http://dx.doi.org/10.1111/1753-0407.13448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667667/
https://www.ncbi.nlm.nih.gov/pubmed/37518861
http://dx.doi.org/10.1111/1753-0407.13448

Ejemplares similares